Lobbyist Public Search Mass. state house
Records prior to registration year 2005 are not available online.

Contact the Lobbyist Division here for assistance. 		Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
Your comments are welcome:  submit feedback
Disclosure reporting details
Back to search detail summary
Lobbyist disclosure reporting period:   07/01/2013 - 12/31/2013
Lobbyist name Mary Kaysen   
Business name Bristol-Myers Squibb Company
Address 104 Valley Street   
City, state, zip code Beverly Farms, MA 01915         
Country US
Agent type Both
Phone 978-232-1147
 
 
Operating Expenses
DateRecipientType of expenseAmount
7/1/2013-12/31/2013 Advertising expenses $0.00
7/1/2013-12/31/2013 Photocopies, scans $0.00
7/1/2013-12/31/2013 Computer equipment, supplies $0.00
7/1/2013-12/31/2013 Professional dues $0.00
7/1/2013-12/31/2013 Fax charges $0.00
7/1/2013-12/31/2013 Internet fees $0.00
7/1/2013-12/31/2013 Legal fees $0.00
7/1/2013-12/31/2013 Postage, shipping, delivery $0.00
7/1/2013-12/31/2013 Office supplies, equipment $0.00
7/1/2013-12/31/2013 Printing expenses $0.00
7/1/2013-12/31/2013 Public relations expenses $0.00
7/1/2013-12/31/2013 Rent $0.00
7/1/2013-12/31/2013 Office and support staff salaries $0.00
7/1/2013-12/31/2013 Professional subscriptions $0.00
7/1/2013-12/31/2013 Taxes $0.00
7/1/2013-12/31/2013 Telephone, cell phone, handheld $0.00
7/1/2013-12/31/2013 Utilities (heat, water, electricity) $0.00
7/1/2013-12/31/2013 Other operating expenses $0.00
  Total operating expenses $0.00
 
Activities, Bill Numbers and Titles
Activity or Bill No and TitleAgent's positionDirect business association with public officialClient representedCompensation received
H1 - An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral none Bristol-Myers Squibb Company $20,712.00
H3400 - An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral none Bristol-Myers Squibb Company $0.00
H3401 An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral none Bristol-Myers Squibb Company $0.00
S3 An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral none Bristol-Myers Squibb Company $0.00
S1800 An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral none Bristol-Myers Squibb Company $0.00
H3538 An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral none Bristol-Myers Squibb Company $0.00
Chapter 224 the Acts of 2012 An Act Improving The Quality Of Health Care and Reducing Costs Through Increased Transparency, Efficiency and Innovation Neutral none Bristol-Myers Squibb Company $0.00
H27 An Act Making Uniform the Law Regarding Trade Secrets Neutral none Bristol-Myers Squibb Company $0.00
H678 An Act Authorizing a Special Commission to Study Cytotoxic Drugs in the Environment Oppose none Bristol-Myers Squibb Company $0.00
H825 An Act Regulating the Disposal of Prescription Medication Neutral none Bristol-Myers Squibb Company $0.00
H931 An Act Relative to Mastectomies Neutral none Bristol-Myers Squibb Company $0.00
H974 An Act Relative to Providing Insurance Coverage for Breast Cancer Screening Neutral none Bristol-Myers Squibb Company $0.00
H978 An Act Relative to Pre-Authorization of Medical and Health Care Services Neutral none Bristol-Myers Squibb Company $0.00
H999 An Act Ensuring Access to Life-Saving Colorectal Cancer and Breast Cancer Screening Support none Bristol-Myers Squibb Company $0.00
S415 An Act Ensuring Access to Life-Saving Colorectal Cancer and Breast Cancer Screening Support none Bristol-Myers Squibb Company $0.00
H1052 An Act Relative to Prescription Drugs Neutral none Bristol-Myers Squibb Company $0.00
H1676 An Act Criminalizing the Possession of Ingredients for Manufactured Drugs Neutral none Bristol-Myers Squibb Company $0.00
H1715 An Act Relative to Non-Competition Agreements Oppose none Bristol-Myers Squibb Company $0.00
H1729 An Act Relative to the Prohibition of Non-Competition Agreements Oppose none Bristol-Myers Squibb Company $0.00
H1927 An Act Relative to the Substitution of Interchangeable Biosimilars Neutral none Bristol-Myers Squibb Company $0.00
H3667 An Act Relative to the Substitution of Interchangeable Biosimilars Neutral none Bristol-Myers Squibb Company $0.00
H3734 An Act Relative to the Substitution of Interchangeable Biosimilars Neutral none Bristol-Myers Squibb Company $0.00
H1933 An Act Establishing Provisions for the Return of Expired Pharmaceuticals Neutral none Bristol-Myers Squibb Company $0.00
H1949 An Act to Allow a Sixty-day Bulk Purchase of Prostate Cancer Neutral none Bristol-Myers Squibb Company $0.00
H1956 An Act to Establish a Statewide Program to Promote Prevention, Diagnosis and Treatment of Type 2 Diabetes Neutral none Bristol-Myers Squibb Company $0.00
H1962 An Act Relative to the Substitution of Generic Drugs Neutral none Bristol-Myers Squibb Company $0.00
H1977 An Act Relative to Drug Disposal by Mail Prescriptions Neutral none Bristol-Myers Squibb Company $0.00
H1978 An Act Relative to Responsible Prescription Prescribing Neutral none Bristol-Myers Squibb Company $0.00
H1988 An Act Relative to Suspending Prescription Drug Coverage from Minimum Creditable Coverage Oppose none Bristol-Myers Squibb Company $0.00
H1933 An Act Relative to the Definition of Pharmacy Neutral none Bristol-Myers Squibb Company $0.00
H2018 An Act to Define Modest Meals and Refreshments in Prescriber Educational Settings Oppose none Bristol-Myers Squibb Company $0.00
H2020 An Act to Reduce Healthcare Costs by Promoting Non-biased Prescriber Education Oppose none Bristol-Myers Squibb Company $0.00
S1050 An Act to Reduce Healthcare Costs by Promoting Non-biased Prescriber Education Oppose none Bristol-Myers Squibb Company $0.00
H2033 An Act Relative to Safe Disposal of Prescription Drugs Oppose none Bristol-Myers Squibb Company $0.00
H2061 An Act Prohibiting Advertising by Pharmaceutical Companies Oppose none Bristol-Myers Squibb Company $0.00
H2065 An Act Relating to the Dispension of Pharmaceuticals with an Aesthetic Purpose by Physicians Neutral none Bristol-Myers Squibb Company $0.00
H2077 An Act Relative to the Safe Dispensing of Pain Management Medication Neutral none Bristol-Myers Squibb Company $0.00
H2081 An Act Providing for the Establishment and Operation of a Cancer Drug Repository Program Neutral none Bristol-Myers Squibb Company $0.00
H2082 An Act Establishing a Statewide Discount Program for Pharmaceuticals Neutral none Bristol-Myers Squibb Company $0.00
S1094 An Act Establishing a Statewide Discount Program for Pharmaceuticals Neutral none Bristol-Myers Squibb Company $0.00
H2096 An Act Establishing a Special Commission to Study and Recommend Improvements in the Delivery of Prescription Drug Benefits for the Citizens of the Commonwealth Oppose none Bristol-Myers Squibb Company $0.00
H2104 An Act to Improve Quality of Life by Expanding Access to Palliative Care Neutral none Bristol-Myers Squibb Company $0.00
H2646 An Act to Eliminate the Tax Deduction for Direct to Consumer Pharmaceutical Marketing Oppose none Bristol-Myers Squibb Company $0.00
S300 An Act Relative to the Prescription Drug Coverage for Seniors and the Disabled Neutral none Bristol-Myers Squibb Company $0.00
S399 An Act Relative to Regulation or Discharge of Pharmaceutical and Personal Care Product Laden Wastewater into Private Drinking Water Wells and Municipal Drinking Water Supplies Oppose none Bristol-Myers Squibb Company $0.00
S439 An Act Relative to Patient Medication Adherence Support none Bristol-Myers Squibb Company $0.00
S471 An Act Relative to Pancreatic Cancer Screening Support none Bristol-Myers Squibb Company $0.00
S477 An Act Relative to Patient Protection Support none Bristol-Myers Squibb Company $0.00
S483 An Act Regulating Pharmacy Audits Oppose none Bristol-Myers Squibb Company $0.00
S484 An Act Regulating Pharmacists as Health Care Providers Neutral none Bristol-Myers Squibb Company $0.00
S493 An Act Relative to Women's Health and Cancer Recovery Neutral none Bristol-Myers Squibb Company $0.00
S543 An Act to Ensure the Privacy of Patient Prescription Records Oppose none Bristol-Myers Squibb Company $0.00
S569 An Act Relative to Mandatory Prescription Drug Coverage Oppose none Bristol-Myers Squibb Company $0.00
S846 An Act Relative to Employee Non-Competition Agreements Oppose none Bristol-Myers Squibb Company $0.00
S1029 An Act Relative to Prescription Drug Adverse Event Reporting Neutral none Bristol-Myers Squibb Company $0.00
S1051 An Act to Prevent Undue Influence on Prescriber Behavior Oppose none Bristol-Myers Squibb Company $0.00
S1052 An Act to Restore Integrity in the Marketing of Pharmaceutical Products and Medical Devices Oppose none Bristol-Myers Squibb Company $0.00
S1090 An Act to Ensure Safe Medication Administration Neutral none Bristol-Myers Squibb Company $0.00
S1220 An Act Relative to Medicare Part B Neutral none Bristol-Myers Squibb Company $0.00
S1334 An Act Updating the Research and Development Tax Credit Neutral none Bristol-Myers Squibb Company $0.00
S1360 An Act Relative to Tax Credits for Prescription Drugs Neutral none Bristol-Myers Squibb Company $0.00
H3415 An Act Relative to Transportation Finance Neutral none Bristol-Myers Squibb Company $0.00
S1770 An Act Relative to Transportation Finance Neutral none Bristol-Myers Squibb Company $0.00
H3535 An Act Relative to Transportation Finance Neutral none Bristol-Myers Squibb Company $0.00
Chapter 95 An Act Repealing the Computer and Software Services Tax Neutral none Bristol-Myers Squibb Company $0.00
S1378 An Act Establishing a Health Care Electronic Prescribing Tax Credit Oppose none Bristol-Myers Squibb Company $0.00
   Total amount $20,712.00
 
Meals, Travel, and Entertainment Expenses
No meals, travel, or entertainment expenses were filed for this disclosure reporting period.
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
DateRecipient nameOffice soughtAmount
12/13/2013 Charlie Baker for Governor Governor $100.00
  Total contributions $100.00
Close this page
William Francis Galvin Secretary of the Commonwealth of Massachusetts
One Ashburton Place
Boston, MA   02108

1-800-392-6090
cis@sec.state.ma.us

Connect with Us

Terms and Conditions     Accessibility Statement